Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Transplantation. 2017 Oct;101(10):2590–2598. doi: 10.1097/TP.0000000000001756

Table 3.

Renal Allograft Loss

RDP Control

LD (n=277) DD (n=148) LD (n=111) DD (n=221)

Death with function, n (%) 139 (50.1) 82 (55.4) 52 (46.8) 117 (52.9)
Chronic rejection, n (%) 33 (11.9) 15 (10.1) 20 (18.0) 33 (14.9)
Chronic allograft nephropathy, n (%) 15 (5.4) 5 (3.4) 5 (4.5) 9 (4.1)
Transplant glomerulopathy, n (%) 18 (6.5) 6 (4.1) 2 (1.8) 4 (1.8)
Patient discontinuation of immunosuppressive medications, n (%) 11 (4.0) 4 (2.7) 1 (0.9) 10 (4.5)
Recurrent disease, n (%) 15 (5.4) 1 (0.7) 4 (3.6) 9 (4.1)
Acute rejection, n (%) 5 (1.8) 7 (4.7) 0 (0) 2 (0.9)

Abbreviations: RDP, rapid discontinuation of prednisone; LD, living donor; DD, deceased donor.